EMD 77697
Latest Information Update: 02 Jul 2001
At a glance
- Originator Merck KGaA
- Class Antipsychotics; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor agonists; Dopamine D2 receptor antagonists
- 
          
            
              Orphan Drug Status
              NoOrphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. 
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 02 Jul 2001 No-Development-Reported for Psychotic disorders in Germany (Unknown route)
- 17 Mar 1998 New profile
- 17 Mar 1998 Preclinical development for Psychotic disorders in Germany (Unknown route)
